contract_awardAwarded Friday, August 21, 2026Analyzed

MODERNA US, INC.: $90.9M Department of Health and Human Services Contract Vehicle

Bullish

Summary

Moderna ($MRNA) received a $90.9M CDC contract for pediatric COVID vaccines for FY2026-2027, providing steady government revenue that represents about 1.3% of its FY2025 revenue. The award reinforces Moderna's position in the government vaccine market.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Moderna receives $90.9M CDC contract for pediatric COVID vaccines, adding ~1.3% to FY2025 revenue.
  • 2.The contract is a two-year IDIQ, providing predictable government revenue through 2027.
  • 3.No directly related legislation was identified; the award is a routine procurement under existing pandemic preparedness programs.

Market Implications

For Moderna ($MRNA), this contract provides a small but steady revenue boost, helping to stabilize its top line as it pivots to other mRNA products. The award signals continued government commitment to COVID vaccine procurement, which may support investor sentiment. However, the impact on stock price is likely muted given the contract's size relative to Moderna's market cap (~$20B). Investors should watch for additional government contracts and pipeline updates.

Full Analysis

The Department of Health and Human Services, through the CDC, awarded Moderna US, Inc. a $90.9M indefinite delivery/indefinite quantity contract for pediatric COVID vaccines under Executive Order 14398. The contract covers the period from June 2026 to May 2027. Moderna, Inc. ($MRNA) is the publicly traded parent company and direct recipient. This contract is a continuation of government procurement for COVID-19 vaccines, specifically targeting the pediatric population. Moderna's financials show a sharp decline from $19.3B revenue in FY2024 to $6.8B in FY2025, with a net loss of $4.7B. The $90.9M award, while modest relative to past revenue, provides a predictable revenue stream for its vaccine business. No directly related legislation was identified among the provided bill signals; the contract appears to be an administrative renewal under existing authorities. Supply chain beneficiaries include contract manufacturing organizations and raw material suppliers, but specific subcontractors are not disclosed. Historically, government vaccine contracts have provided stable, multi-year revenue for pharmaceutical companies, though the COVID vaccine market has contracted significantly from peak levels.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$MRNA▲ Bullish
Est. $90.9M$90.9M revenue impact

What the bill does

Direct contract award for pediatric COVID vaccine supply

Who must act

Centers for Disease Control and Prevention (HHS) awards Moderna US, Inc. (Moderna, Inc.)

What happens

$90.9M added to Moderna's government vaccine revenue over FY2026-2027, representing ~1.34% of FY2025 annual revenue ($6.8B)

Stock impact

Moderna is a pure-play mRNA vaccine company; this contract provides stable demand for its pediatric COVID vaccine franchise, partially offsetting declining overall revenue from COVID vaccines as the pandemic transitions to endemic phase.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Contract Details

Recipient

MODERNA US, INC.

Award Amount

$90,917,705

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Disease Control and Prevention

Contract Type

INDEFINITE DELIVERY / INDEFINITE QUANTITY

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →